021-51111890
购物车（）
sales@molnova.cn
Mesdopetam hemitartrate
CAS No. 2562346-14-7
Mesdopetam hemitartrate ( 1-?Propanamine, N-?[2-?[3-?fluoro-?5-?(methylsulfonyl)?phenoxy]?ethyl]?-?, (2R,?3R)?-?2,?3-?dihydroxybutanedioat?e (2:1); IRL790 hemitartrate )
产品货号. M28670 CAS No. 2562346-14-7
Mesdopetam hemitartrate is an antagonist of dopamine D3 receptor (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥389 | 有现货 |
|
| 5MG | ￥648 | 有现货 |
|
| 10MG | ￥915 | 有现货 |
|
| 25MG | ￥1839 | 有现货 |
|
| 50MG | ￥3467 | 有现货 |
|
| 100MG | ￥5176 | 有现货 |
|
| 500MG | ￥11097 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Mesdopetam hemitartrate
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Mesdopetam hemitartrate is an antagonist of dopamine D3 receptor (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor).
-
产品描述Mesdopetam hemitartrate is an antagonist of dopamine D3 receptor (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor). It has psychomotor stabilizing properties.
-
同义词1-?Propanamine, N-?[2-?[3-?fluoro-?5-?(methylsulfonyl)?phenoxy]?ethyl]?-?, (2R,?3R)?-?2,?3-?dihydroxybutanedioat?e (2:1); IRL790 hemitartrate
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体p38α
-
研究领域——
-
适应症——
化学信息
-
CAS Number2562346-14-7
-
分子量700.8
-
分子式C28H42F2N2O12S2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCCNCCOC1=CC(S(=O)(C)=O)=CC(F)=C1.CCCNCCOC2=CC(S(=O)(C)=O)=CC(F)=C2.O=C(O)[C@H](O)[C@@H](O)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Baker W, et al. Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and β-agonists for the treatment of pulmonary inflammation and bronchoconstriction. WO 2008076265 A1.
产品手册
关联产品
-
L-(-)-α-Methyldopa
Methyldopa is an alpha-adrenergic agonist (selective for α2-adrenergic receptors) psychoactive drug used as a sympatholytic or antihypertensive.
-
Levosulpiride
Levosulpiride is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class.
-
CCT241736
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.
